The document discusses the company's financial performance in the last quarter of 2022. Revenue was up 10% compared to the same period last year, driven primarily by growth in the technology and healthcare sectors. However, expenses also rose due to increased investment in R&D and marketing, resulting in net income being flat compared to last year.
